Rayner
Manufacturer of ophthalmic medical products.
🤖
AI Overview
With $540K in lobbying spend across 11 quarterly filings, Rayner is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
$540K
Total Spend
3
Years Active
1
Firms Hired
6
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $60K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Medicare/Medicaid
- •Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and othe
- •Medicare coverage issue for non-opioid product.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.